DIRS.INFO The most relevant business & tech news

MEXICO CITY (AP) — A Mexican Supreme Court ruling that invalidated all federal criminal penalties for abortion continued a regional trend of widening access to the procedure, but left in place a patchwork of varying state restrictions. Political Cartoons on World Leaders View All 226 ImagesPolitical Cartoons View All 1146 ImagesSome 20 Mexican states, however, still criminalize abortion. Those laws were not affected by the Supreme Court ruling, but abortion rights advocates will likely ask state judges to follow its logic. Abortion-rights activists will have to continue seeking legalization state by state, though Wednesday's decision should make that easier. Some American women were already seeking help from Mexican abortion rights activists to obtain pills used to end pregnancies.

Persons: Sen, Olga Sánchez Cordero, Irma Barrientos, We’re, ” Barrientos, “, we’re, Fernanda Díaz de, de León, Díaz de León, León, Roe, Wade, Marina Reyna, ”, Geoff Mulvihill Organizations: MEXICO CITY, Court, Group, National Institute for Women, Twitter, Civil Association for, U.S, Supreme, Observers, Guerrero, Women, Associated Locations: MEXICO, “, United States, Mexico, Aguascalientes, America, Mexico City, Argentina, Colombia, Guerrero, Cherry Hill , New Jersey

MEXICO CITY (AP) — Mexico’s Supreme Court threw out all federal criminal penalties for abortion Wednesday, ruling that national laws prohibiting the procedure are unconstitutional and violate women’s rights in a sweeping decision that extended Latin American’s trend of widening abortion access. Some 20 Mexican states, however, still criminalize abortion. After 40 years, the Supreme Court reversed its abortion decision, and we’re not going to stop until Mexico guarantees the right to life from the moment of conception." Some American women were already seeking help from Mexican abortion rights activists to obtain pills used to end pregnancies. Her state decriminalized abortion last year, but there are 22 open investigations against women accused of ending their pregnancies.

Persons: —, “, Sen, Olga Sánchez Cordero, Irma Barrientos, We’re, ” Barrientos, we’re, Fernanda Díaz de, de León, Díaz de León, León, Roe, Wade, Marina Reyna, ”, Geoff Mulvihill Organizations: MEXICO CITY, Group, National Institute for Women, Twitter, Civil Association for, U.S, Supreme, Observers, Guerrero, Women, Associated Locations: MEXICO, “, United States, Mexico, Aguascalientes, America, Mexico City, Argentina, Colombia, Guerrero, Cherry Hill , New Jersey

☆ Disney's wildest ride: Iger, Chapek and the making of an epic succession mess
▼ + stars: | 2023-09-06 | by ( Alex Sherman | ) www.cnbc.com time to read: +88 min

Iger told Chapek that he lived for those "two-shower days," according to people familiar with the conversation. In January 2020, Iger told Chapek the plan was back on. During his 27 years at the company, Chapek had only attended one annual meeting — as a guest in the audience. Bob Iger, Disney CEO, during a CNBC interview, Feb. 9, 2023. WATCH: Disney CEO Bob Iger's exclusive July 2023 CNBC interviewTake the 'A'During Chapek's tenure as CEO, Disney lost more than a quarter of its market value.

Persons: Elham, Bob Iger, Bob Chapek, Iger, wasn't, Chapek, Michael Eisner, —, who's, he's, Clint Eastwood, Eastwood, Arthur Bochner, Jackie Hart, Kareem Daniel, Chapek —, Eisner, Michael Ovitz, Ovitz, Bob, Disney's, Kevin Mayer, Mayer, Bryan van der Beek, he'd, Tom Staggs, Staggs, Staggs —, Steve Jobs, cajoled Ike Perlmutter, George Lucas, Rupert Murdoch, Iger's, Susan Arnold, Arnold, Peter Rice, David Paul Morris, Rice, CNBC's Julia Boorstin, Mark Parker, Mary Barra, Michael Froman, Willow, Parker, John Donahoe, Roy Disney, Walt Disney, Stanley Gold, David A, CNBC Eisner, Big Bob, Little Bob, Christine McCarthy, Patrick T, He'd, McCarthy, Iger —, Coronavirus, Gavin Newsom, Michael Kovac, curtly, Nancy Pelosi, Chuck Schumer, Ben Smith, Smith, Disney, Randy Shropshire, Agnes Chu, Ricky Strauss, Chu, Strauss, Kevin Feige, Kathleen Kennedy, Who's, Alan Bergman, Bergman, Bob Kyncl, Daniel —, Iger didn't, Daniel rankled, Daniel, Chapek didn't, James Pitaro, Jesse Grant, CNBC Chapek, Jimmy Pitaro, Zenia Mucha, didn't, Mucha, Barbara Walters, Charles Eshelman, Scarlett Johansson, Scarlett Johansson —, Florence Pugh, Natasha, Yelena, " Johansson, Bryan Lourd, Johansson, Lourd, Steven Spielberg, Al Michaels, David Muir, Robin Roberts, Michael Strahan, Spielberg, Geoff Morrell, Alan Braverman, Alan Horn, Jayne Parker, Bochner, Claire Lee, Paul Richardson, Josh D'Amaro, Ron DeSantis, Morrell, Disney Animation —, George Floyd, Reba Saldanha, Reuters Chapek, DeSantis, Nicholas Maldonado, Octavio Jones, Chapek she'd, we're, " Morrell, CNN's Chris Wallace, Kristina Schake, John Skipper, Daniel steamrolled, Latondra Newton, Newton, Charles Krupa, Pitaro, NBCUniversal's Peacock, Dana Walden, Thomas Murphy, Josh Kushner, Privately, Schake, Barack Obama, Michelle Obama, Michelle Obama's, David Dee Delgado, Kara Swisher, hadn't, Netflix's, overhiring, McCarthy hadn't, Safra Catz, Kareem, DMED, Horacio Gutierrez, Justin Warbrooke, Alexia Quadrani, Bryan Castellani, Michael Buckner, Quadrani, Lindsay Lohan, Winnie, Nelson Peltz, Catz, Donald Trump's, they'd, Walden, Gutierrez, D'Amaro, Rich Polk, Walden he'd, Iger she'd, Mickey Mouse, Mark Rightmire, haven't, Indiana Jones, Halle Bailey, Ariel, Hamilton Faber, Rich Greenfield, Bob Iger's, — Mayer, McCarthy —, doesn't, they'll Organizations: Disney, Marvel, CNBC, Bloomberg, Getty, Walt Disney, Indiana University, Michigan State University, Shanghai Disney, Man, Hong Kong Disneyland, Walt Disney Parks, Resorts, Pixar, Fox, Chapek, Nike, General, Mastercard, Foreign Relations, University of Pennsylvania, Grogan, Disney's, Fallon, ABC, ESPN, ABC News, California Gov, New York Times, Disney confidants, Hollywood, Marvel Studios, Lucasfilm, Walt Disney Television, Walt Disney Studios, Hulu, HBO Max, Walt Disney Company, YouTube, Companies, Netflix, Apple, Disney Media, Entertainment, Stanford, Rights, Junior, petulant, Filmmagic, Brunswick Group, Covid, CAA, onetime Defense Department, Century Fox, Human, Florida Gov, Republican, Disney Animation, Reuters, Human Rights, HRC, Walt Disney World, Employees, American Foundation for Equal Rights, AP, Amazon Prime, Paramount, South Pacific, Capital Cities, Dow Jones, CVS, Kingdom, Variety, Trian Partners, Charter Communications, U.S, Comcast, Charter's, MediaNews, Orange, Allen, Co, Candle Media, Advisors Locations: Burbank , California, Midwestern, Brentwood, Los Angeles, Westlake Village, Iger, Hammond , Indiana, Shanghai, China, Hong, Fox, Willow Bay, Raleigh , North Carolina, Orlando, U.S, Hulu, Iger's Brentwood, coronavirus, Brunswick, Hollywood, Hawaii, Disney's, Marvel's, Anaheim , California, Montana, Florida, Rye , New Hampshire, Chapek, Hong Kong, California, missteps, South, DMED, Burbank, New York, India, Atlantic, Sun Valley , Idaho, America

☆ Seen from Close-up: How the U.S. Open Dials in its Court Speed
▼ + stars: | 2023-09-02 | by ( Helmuth Rosales | Geoff Macdonald | ) www.nytimes.com time to read: +7 min

Seen from Close-up: How the U.S. Open Dials in its Court SpeedFrom the seats in Arthur Ashe Stadium, the tennis court below appears smooth and uniform. The size, shape and density of the sand make up the hardcourt surface and dictate the speed of the ball after it bounces. Of course, players are not always universally happy with the court surface choices made for the tournaments on the pro tours. The court surface used at Flushing Meadows is called Laykold, which is made by Advanced Polymer Technology, an international manufacturer of sports surfaces. The bounce of a tennis ball generally lasts five milliseconds, an instant that will determine how the ball behaves.

Persons: Arthur Ashe, ”, Ben Depoorter, “, Suresh Ponnusamy, Helmuth Rosales, Daniil Medvedev, ” Medvedev, Medvedev, Indian Wells, Carlos Alcaraz, Swiatek –, Rafael Nadal, hardcourts, Wesley Baum, Taylor Fritz, Coco Gauff, Elena Rybakina, Roger Federer, — Swiatek, Aryna, Alcaraz, Novak Djokovic — Organizations: U.S, U.S ., United States Tennis Association, BNP, Tennis Federation, Polymer Technology, Helmuth Rosales Professional, Wimbledon, Miami, Indian, Advanced Polymer Technology, Flushing Locations: Ashe, Indian Wells, Calif, Indian, Miami, Flushing Meadows

Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. Medtronic, which makes pacemakers, catheters and other tools used in heart and gastrointestinal surgeries, joins rivals, including Abbott Laboratories (ABT.N), Stryker (SYK.N) and Boston Scientific (BSX.N), on benefiting from a rise in non-urgent surgeries. CEO Geoff Martha said trends pointed to a recovery in surgical volumes as some procedures returned to stronger than pre-pandemic levels. Whereas, revenue from its medical surgical unit rose 5.5% to $2.04 billion. Medtronic also said that it was expecting to split its patient monitoring and respiratory interventions businesses in the first half of fiscal 2025.

Persons: Dado Ruvic, Stryker, Geoff Martha, It's, Martha, Edward Jones, John Boylan, Medtronic, Bhanvi Satija, Christy Santhosh, Shweta Agarwal Organizations: REUTERS, Abbott, Abbott Laboratories, Boston, Thomson Locations: Dublin, Bengaluru

☆ Here's a list of weight-loss drugs in development and awaiting approval to take on Ozempic
▼ + stars: | 2023-06-28 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +10 min

The company's chief rival, Denmark-based Novo Nordisk (NVO), also published promising data on drugs in its pipeline, including its own oral weight-loss treatment. Other pharmaceutical companies are racing to compete with Novo Nordisk and Eli Lilly, including Amgen (AMGN) and Pfizer (PFE). Barclays on Tuesday projected Eli Lilly's three leading obesity-and-diabetes drugs could generate nearly $49 billion in combined sales in 2030. Eli Lilly Eli Lilly has multiple drugs in development that fall under the GLP-1 umbrella in various stages of clinical development. Novo Nordisk Novo Nordisk currently dominates the market for GLP-1 drugs, with three products in the class on the U.S. market already: Ozempic, Wegovy and Rybelsus.

Persons: It's, Eli Lilly, Eli Lilly's, retatrutide, Lilly, there's, Lilly's, Geoff Meacham, Eli Lilly Eli Lilly, Jim Cramer, Evan David Seigerman, —, — Morgan Stanley, Wegovy, Rybelsus, Jim Cramer's, Jim, Mike Segar Organizations: Club, Novo Nordisk, New England, of Medicine, American Diabetes Association, Pfizer, Reuters, Barclays, Bank of America, CNBC, JPMorgan, Drug Administration, Equity, BMO Capital, Novo Nordisk Novo Nordisk, GLP, FDA, Nordisk, Company Locations: San Diego, Denmark, GLP, It's, Novo, Novo Nordisk's, Branchburg , New Jersey

☆ Eli Lilly's weight loss drugs trounce sky-high expectations, boosting the stock
▼ + stars: | 2023-06-27 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +5 min

What's more, some showed no signs their weight loss was leveling off, suggesting they could continue to shed pounds. (Both use semaglutide, but Ozempic is marketed as a type 2 diabetes treatment, while Wegovy is primarily for weight loss.) Bank of America's Geoff Meacham said retatrutide "exceeded expectations" for weight loss. "This is important, as while the overall 22.4% weight loss was impressive, looking at men and women separately, weight loss was 21.9% and 28.5%, respectively, with the slope in females not yet plateauing. Schott also described the weight loss as "impressive" and said it will likely compare favorably with Novo's next-generation drug CagriSema, which is expected to show weight loss of more than 25% when it releases its next update.

Persons: Eli Lilly, What's, Lilly, Lilly's, Carter Gould, Gould, orforglipron, Bank of America's Geoff Meacham, retatrutide, Meacham, Chris Schott, Schott, Novo's, Evan David Seigerman, Seigerman, Morgan Stanley, Terence Flynn, — CNBC's Michael Bloom Organizations: American Diabetes Association, Wall, Novo Nordisk, Barclays, Bank of America's, JPMorgan, Lilly, BMO Capital, Indianapolis, ~$ Locations: Novo

☆ New data fortifies Eli Lilly's standing in the burgeoning market for weight-loss drugs
▼ + stars: | 2023-06-26 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +5 min

Eli Lilly (LLY) bolstered its position in the budding weight-loss drug market after new data showed its oral obesity pill was highly effective in a mid-stage study. Eli Lilly shares are taking a breather Monday, but we see no reason to join the sellers. Eli Lilly funded the trial. Eli Lilly stock is down about 1.3% Monday afternoon, likely on some profit-taking following a solid move up last week. Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.

Persons: Eli Lilly, LLY, orforglipron, Orforglipron, Eli Lilly's Mounjaro, Mounjaro, Jim Cramer, Lilly's, Geoff Meacham, Meacham, Lilly, It's, we've, Jim Cramer's, Jim, Cristina Arias Organizations: Club, New England, of Medicine, Nordisk, U.S . Food, Drug Administration, Novo Nordisk, Sunday, Bank of America, CNBC, UBS, Pfizer, Company, Pharmaceutical Locations: U.S, Alcobendas, Madrid, Spain

☆ Obesity weight loss market will remain a duopoly between Novo Nordisk and Eli Lilly: BofA’S Meacham
▼ + stars: | 2023-06-26 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailObesity weight loss market will remain a duopoly between Novo Nordisk and Eli Lilly: BofA’S MeachamGeoff Meacham, Bank of America Securities, joins 'Fast Money to discuss the state of the weight-loss drug market as Eli Lilly and Novo Nordisk compete for market share.

Persons: Eli Lilly, BofA’S Meacham Geoff Meacham Organizations: Novo Nordisk, Bank of America Securities

☆ Estonia becomes first ex-Soviet state to legalize same-sex marriage
▼ + stars: | 2023-06-20 | by ( Catherine Nicholls | ) edition.cnn.com time to read: +2 min

CNN —Estonia’s parliament passed on Tuesday a law legalizing same-sex marriage, becoming the first ex-Soviet country to do so. Two adults will be able to marry “regardless of their gender,” after the parliament approved amendments to the country’s Family Law Act, according to a press statement. The amendments to the Family Law Act also mean that same-sex couples can now adopt children. Geoff Moore/ShutterstockSame-sex relationships have been legally recognized in Estonia since 2016, when the Registered Partnership Act took effect. “I am delighted that the decision has now been taken for a more forward-looking Estonia that cares for all.”

Persons: CNN —, Kaja Kallas, ”, Geoff Moore, “, Signe Riisalo, ” Riisalo Organizations: CNN, ”, Estonian Human Rights, Estonia’s, Social Locations: Soviet, Estonia, Tallinn

☆ Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
▼ + stars: | 2023-04-18 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

International Covid vaccine sales helped spark Johnson & Johnson 's revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. That marks the end of a rocky three years for J&J's Covid vaccine despite being one of the first shots to enter the U.S. market during the pandemic. Notably, all Covid vaccine revenue during the quarter came from outside of the U.S. JP Morgan analyst Chris Schott added that J&J's first-quarter beat was in part "driven by Covid vaccine upside." While J&J's vaccine fell out of favor in the U.S. and other wealthy countries, developing countries have continued to rely on it.

☆ Earnings playbook: Netflix and Goldman Sachs headline a big week of reports
▼ + stars: | 2023-04-16 | by ( Fred Imbert | ) www.cnbc.com time to read: +14 min

Tuesday Johnson & Johnson is set to report earnings before the open, followed by a call with management at 8:30 a.m. Goldman Sachs is set to report earnings before the open, followed by a call at 9:30 a.m. What history shows: Bespoke data shows Goldman tops earnings expectations 86% of the time. Netflix is set to report earnings after the bell, followed by a call with management at 6 p.m. Friday Procter & Gamble is set to report earnings before the open, with a conference call also slated for 8:30 a.m.

☆ Johnson & Johnson shares rise after company proposes baby powder cancer settlement
▼ + stars: | 2023-04-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Johnson & Johnson shares on Wednesday climbed after the company proposed paying $8.9 billion to settle thousands of claims that its baby powder and other talc products caused cancer. The pharmaceutical giant also said its subsidiary LTL Management refiled for Chapter 11 bankruptcy protection after its first attempt faced legal challenges. JPMorgan analyst Chris Schott on Thursday called the proposed settlement a positive for the company in a note. The proposed $8.9 billion settlement is also in-line with JPMorgan's $8 billion to $10 billion estimate, Schott noted. It's also unclear whether the proposed settlement will win approval in bankruptcy court, Bank of America analyst Geoff Meacham noted Thursday.

☆ ‘We Have a Ghost’ Review: A Haunted House Hits Social Media
▼ + stars: | 2023-02-24 | by ( John Anderson | ) www.wsj.com time to read: +1 min

The first scene in “We Have a Ghost” involves an entire family running out of their house screaming, jumping in their car and tearing away. Still, there’s a scary amount of stuff going on in writer-director Christopher Landon ’s horror movie/murder mystery/domestic drama/deep-state thriller/coming-of-age teenage romance. It may be based on the short story “Ernest” by Geoff Manaugh . A year later, looking for a new start, the family of young Kevin Presley (Jahi Winston) moves in, having been kept in the dark by their broker (Faith Ford) about the house’s blighted history. When Kevin first meets up with Ernest (that’s what it says on his bowling shirt), the boy laughs at the ghost’s boogeyman routine, befriending him instead.

☆ Clearing out the inflation on our balance sheet is a four to eight month cycle for us, says Medtronic CEO
▼ + stars: | 2023-02-21 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailClearing out the inflation on our balance sheet is a four to eight month cycle for us, says Medtronic CEOMedtronic CEO Geoff Martha joins CNBC's Jon Fortt on 'Closing Bell: Overtime' to discuss how inflation is impacting his company.

☆ Eli Lilly investors spooked by weak Mounjaro sales, but it's the obesity drug approval that will unlock its value
▼ + stars: | 2023-02-02 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +5 min

Lilly said slightly more than 50% of commercial and Part D subscribers have access to the drug via their insurance plans. But new classes of weight loss medications are helping to change this mindset. Still, legislation will be necessary to get coverage of Mounjaro for obesity and overweight treatment by Medicare plans. By law, these plans are banned from paying for weight loss medications. Wegovy and Mounjaro One encouraging sign: Lilly competitor Novo Nordisk has gained access to more than 80% of insurance company formularies for their obesity treatment, Wegovy.

New York CNN —Jonathan Pulliam has been working at Disney World since 2018, dressing up as everything from beloved Disney cartoon characters to Star Wars villains. Those working under this contract, all of them full-time employees, represent more than 40% of all workers at Disney World. “A dollar does not afford Disney workers with the ability to keep up with the skyrocketing rent increases. Union leadership said they hope that Disney will return to the table with a better offer once union members reject this one. Unions have represented workers at Disney World since soon after the park’s 1971 opening, but employees have never gone on strike.

☆ Analysis: This guy made $150,000 a day, because Corporate America is out of control
▼ + stars: | 2023-01-23 | by ( Allison Morrow | ) edition.cnn.com time to read: +7 min

I’m seeing the words “recession,” “crypto,” “debt ceiling,” the “M&M’s spokescandy scandals…”And yet, I am bound my duty as a journalist not to shy away from the hard candy shell news. I know, I know, you’re all tired of the media’s relentless coverage of the M&M Spokescandy Saga, aka the Culture War Battle that is shaping social discourse in the Year of Our Lord 2023. The company claims it didn’t think anyone would notice when it released the changes to the characters’ appearance. “We definitely didn’t think it would break the internet,” it said in a press release that frankly reeked of champagne and high fives. Oh you didn’t think anyone would notice, M&M marketing wizards?

☆ Geoff Morell: Fired Disney exec had a short, very lucrative tenure at the company
▼ + stars: | 2023-01-23 | by ( Chris Isidore | ) edition.cnn.com time to read: +5 min

He became Disney’s chief corporate affairs officer January 24, 2022, and the company promptly announced Morrell’s departure in late April. That $4 million will be in addition to the $8.3 million in compensation reported for last year. The former Disney PR chief received more than $100,000 a day for his short tenure at the media company in 2022. Before that he helped see BP (BP) through the Deepwater Horizon disaster and the resulting oil spill. Morrell’s departure from Disney was announced within days of that dust-up.

☆ Eli Lilly's Alzheimer's drug hits a regulatory hurdle. But our belief in the stock isn't shaken
▼ + stars: | 2023-01-20 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +8 min

Eli Lilly 's (LLY) attempt to receive accelerated regulatory approval for its Alzheimer's drug donanemab has been rejected. Eli Lilly said it will keep working with the FDA to "evaluate the fastest pathway" for donanemab to reach patients. Indeed, analysts at Barclays wrote in a note to clients Thursday that "we now see [accelerated approval] off the table." LLY 1Y mountain Eli Lilly (LLY) 1-year performance "It's definitely not a thesis-breaker," Bank of America analyst Geoff Meacham told CNBC on Friday. David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC

☆ A Disney executive who left after 3 months amid its 'Don't Say Gay' missteps made almost $120,000 a day
▼ + stars: | 2023-01-19 | by ( Grace Dean | ) www.businessinsider.com time to read: +4 min

Disney faced intense criticism over its slow response to Florida's "Don't Say Gay" bill. During his time at the company, Morrell got a $489,500 salary, Disney's proxy statement released on Tuesday shows. The Wall Street Journal first reported on Morrell's compensation. But during Morrell's tenure the company faced intense criticism over its response to Florida's "Don't Say Gay" law. However, in a copy of Morrell's general release from the company, Disney said that it had exercised its termination right in late April.

☆ The Disney Executive Who Made $119,505 a Day
▼ + stars: | 2023-01-18 | by ( Erich Schwartzel | ) www.wsj.com time to read: 1 min

Geoff Morrell, Disney’s former chief corporate-affairs officer, was an outsider, having worked for years in the Pentagon and at BP PLC. Even by show-business standards, former Walt Disney Co. executive Geoff Morrell netted a massive payday from his brief time in Hollywood. Mr. Morrell started working at Disney on Jan. 24, 2022, as the company’s chief corporate-affairs officer. He left less than four months later following a public-relations implosion that led to employee protests and pitted the company and then-CEO Bob Chapek against Florida Gov. Ron DeSantis .

☆ Eli Lilly has spent years and billions of dollars in search of an effective Alzheimer's drug. But success is not all or nothing for the stock
▼ + stars: | 2023-01-09 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +22 min

Eli Lilly (LLY) has spent decades researching Alzheimer's disease without successfully bringing to market a treatment that slows the memory-destroying condition. For Eli Lilly as a company, an Alzheimer's drug is an important pursuit. Lilly's Alzheimer's history Eli Lilly's "first real foray" into Alzheimer's came in the 1990s, according to Dr. John Sims, Eli Lilly's head of medical development for donanemab. Financial implications for Lilly LLY mountain 2021-10-08 The Club started a new position in Eli Lilly (LLY) in October 2021. The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.

☆ Bank of America upgrades Merck, says pharma giant will outperform even as macro pressures mount
▼ + stars: | 2023-01-04 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

Investors can expect further gains from Merck this year, Bank of America said. Analyst Geoff Meacham upgraded shares to buy from neutral, saying the pharmaceutical company will continue to outperform even as macro pressures mount in 2023. Merck's core business in Keytruda continued to show strong performance, and it has several strategies in place for the loss of exclusivity. Loss of exclusivity is the set amount of time a pharmaceutical company can legally develop, sell and market a treatment. Keytruda is expected to be greater than 45% of Merck's total revenue in 2025, according to the note.

☆ Bank of America reveals its 'best-in-class' stocks for 2023
▼ + stars: | 2022-12-17 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Analysts at Bank of America unveiled this week a slew of must-own stocks for 2023. CNBC Pro combed through recent research to find Bank of America's 'best-in-class" stocks heading into next year. "Although 2022 has been a year of modest growth for Lilly, shares have outperformed based largely on tirzepatide's peak potential," he wrote. Eli Lilly "Although 2022 has been a year of modest growth for Lilly, shares have outperformed based largely on tirzepatide's peak potential. Given this backdrop, Lilly remains a top pick, as we see its new product cycle / LT growth as clearly best-in-class."

Search resuls for: "Geoff M"

25 mentions found